Senti Biosciences Inc.

SNTI | $0.31 0.92% 48K

(0.0% 1d) (-26.4% 1m) (-69.0% 1y) (0.0% 2d) (3.3% 3d) (-8.4% 7d) (-70.07% volume)
Earnings Calendar:
Market Cap: $ 14,184,057

Sec Filling | Patents | 4 employees

senti biosciences is a team of engineers, scientists, and entrepreneurs on a mission to leverage synthetic biology to treat the most pressing diseases. they have pioneered new technology platforms to design synthetic gene circuits for adaptive cell and gene therapies. their recently completed series a round of funding will be used to further the growth of their scalable therapeutic design platform and advance therapeutic candidates towards the clinic. they are proud to count nea, 8vc, amgen ventures, pear ventures, lux capital, menlo ventures, allen & company, nest.bio, omega funds, goodman capital, and lifeforce capital among their investors.

t-cell

add to watch list Paper trade email alert is off